Lackland Air Force Base
San Antonio, Texas, 78236, United States
NCT Number: NCT00330798
The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 4
San Antonio, Texas, 78236, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nepafenac 0.1% randomly assigned to one eye, with ketorolac 0.4% in the fellow eye for contralateral post-surgical use.
Keterolac 0.4% randomly assigned to one eye, with nepafenac 0.1% in the fellow eye for contralateral post-surgical use.
Time frame: Day 5
Time frame: Time to event
Alcon Research
Industry
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04704518
Corneal De-epithelialization, Photorefractive Keratectomy
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT05477875
Eye Diseases, Hyperopia
Gainesville, Florida, United States
View Trial DetailsNCT04281004
Photorefractive Keratectomy
Salt Lake City, Utah, United States
View Trial DetailsNCT05973253
Photorefractive Keratectomy
Isfahan, Iran
View Trial Details